[1]董孟杰,林祥通,赵军.PET-CT在卵巢癌中的临床应用价值[J].国际放射医学核医学杂志,2005,29(5):209-213.
　DONG Meng-jie,LIN Xiang-tong,ZHAO Jun.The application of PET-CT in ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):209-213.
点击复制

PET-CT在卵巢癌中的临床应用价值(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
29
期数:
2005年第5期
页码:
209-213
栏目:
PET-CT技术
出版日期:
1900-01-01

文章信息/Info

Title:
The application of PET-CT in ovarian cancer
作者:
董孟杰;  林祥通;  赵军
200040 上海, 复旦大学附属华山医院核医学科
Author(s):
DONG Meng-jie;  LIN Xiang-tong;  ZHAO Jun
Department of Nuclear Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China
关键词:
卵巢癌; 正电子发射体层显像; 计算机体层成像; 18F-氟代脱氧葡萄糖
Keywords:
ovarian carcinoma; positron emission tomography; computed tomography; 18F-fluorodeoxyglucose
分类号:
R814.42;R817.4
摘要:
卵巢癌是妇科较常见的恶性肿瘤及致死原因,正电子发射体层显像(PET)对于卵巢癌的诊断、分期、复发及疗效监测及预后方面优于常规的检测手段(CT、MRI及肿瘤标志物检查);PET-CT对指导手术有重要价值;特异性PET显像剂的研制已取得初步成果,124I-C6.5 diabody已经成功用于动物的PET-CT。
Abstract:
Ovarian cancer is the leading cause of death among women with gynecologic malignancies, 18F-fluorodeoxyglucose (18SF-FDG) positron emission tomography (PET) is a well-established method for detecting, staging, cancer recurrence and therapeutic response and prognosis of ovarian cancer. PET-CT is helpful for the surgry guide and second-look laparotomy. Specific radiolabel pharmacies to ovarian cancer such as 124I-C6.5 diabody has been successfully imaged in animal with PET-CT.

参考文献/References:

1 Kurokawa T, Yoshida Y, Kawahara K, et al. Expression of GLUT-1glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fiuorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary[J]. Int J Cancer,2004, 109(6):926-932.
2 Torizuka T, Kanno T, Futatsubashi M, et al. Imaging of gynecologic tumors:comparison of (11)C-choline PET with (18)F-FDG PET[J].J Nucl Med,2003, 44(7):1051-1056.
3 Robinson MK, Doss M, Shaller C, et al. Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody[J]. Cancer Res, 2005,65(4):1471-1478.
4 Nishizawa S, Inubushi M, Okada H. Physiological 18F-FDG uptake in the ovaries and uterus of healthy female volunteers[J]. Eur J Nucl Med Mol Imaging, 2005, 32(5):549-556.
5 Torizuka T, Nobezawa S, Kanno T, et al. Ovarian cancer recurrence:role of whole-body positron emission tomography using2-[fluorine-18]-fluoro-2-deoxy-D-glucose[J]. Eur J Nucl Med Mol Imaging, 2002, 29(6):797-803.
6 Nakamoto Y, Saga T, Ishimori I, et al. Clinical value of positron emission tomography with FDG for recurrent ovarian cancer[J]. Am J Roentgenol, 2001, 176(6):1449-1454.
7 Menzel C, Dobert N, Hamscho N, et al. The influence of CA 125and CEA levels on the results of (18)F-deoxyglucose positron emission tomography in suspected recurrence of epithelial ovarian cancer[J]. Strahlenther Onkol, 2004, 180(8):497-501.
8 Havrilesky LJ, Kulasingam SL, Matchar DB, et al. FDG-PET for management of cervical and ovarian cancer[J]. Gynecol Oncol,2005, 97(1):183-191.
9 Kim EE. Whole-body positron emission tomography and positron emission tomography/computed tomography in gynecologic oncology[J]. Int J Gynecol Cancer, 2004, 14(1):12-22.
10 Unger JB, Ivy JJ, Connor P, et al. Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women[J]. Gynecol Oncol, 2004, 94(1):212-216.
11 Chang WC, Hung YC, Lin CC, et al. Usefulness of FDG-PET to detect recurrent cervical cancer based on asymptomatically elevated tumor marker serum levels-a preliminary report[J]. Cancer Invest,2004, 22(2):180-184.
12 Makhija S, Howden N, Edwards R, et al. Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma:a retrospective review[J].Gynecol Oncol, 2002, 85(1):53-58.
13 Bristow RE, delCarmen MG, Pannu HK, et al. Clinically occult recurrent ovarian cancer:patient selection for secondary cytoreduc-tive surgery usingcombinedPET/CT[J]. GynecolOncol, 2003, 90(3):519-528.
14 Casey MJ, Gupta NC, Muths CK. Experience with positron emission tomography (PET) scans in patients with ovarian cancer[J]. Gynecol Oncol, 1994, 53(5):331-338.
15 Rose PG, Faulhaber P, Miraldi F, et al. Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma:correlation with second-look laparotomy[J]. Gynecol Oncol, 2001, 82(1):17-21.
16 Zimny M, Siggelkow W, Schroder W, et al. 2-[Fluorine-18]-fluoro2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer[J]. Gynecol Oncol, 2001, 83(2):310-315.
17 Miller TR, Grigsby PW. Measurement oftumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treat-ed by radiation therapy[J]. Int J Radiat Oncol Biol Phys, 2002, 53(2):353-359.
18 Barranger E, Kerrou K, Petegnief Y. Laparoscopic resection of occult metastasis using the combination of FDG-positron emission tomography/computed tomography image fusion with intraoperative probe guidance in a woman with recurrent ovarian cancer[J]. Gynecol Oncol, 2005, 96(1):241-244.
19 Smith GT, Hubner KF, McDonald T, et al. Cost analysis of FDG PET for managing patients with ovarian cancer[J]. Clin Positron Imaging, 1999, 2(2):63-70.

相似文献/References:

[1]左传涛.脑中风患者脑功能重塑研究中应注意的问题[J].国际放射医学核医学杂志,2005,29(1):1.
　ZUO Chuan-tao.The issues in the study of brain plasticity after stroke[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):1.
[2]蔡莉,李彦生.氟代脱氧葡萄糖与氨基酸PET在脑肿瘤中的对比研究[J].国际放射医学核医学杂志,2005,29(1):10.
　CAI Li,LI Yan-sheng.Comparison of 18F-FDG and amino acid PET imaging in brain tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):10.
[3]董爱生,田建明.部分癫痫的神经影像学诊断[J].国际放射医学核医学杂志,2005,29(4):148.
　DONG Ai-sheng,TIAN Jian-ming.Neuroimaging in the diagnosis of partial epilepsy[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):148.
[4]季仲友.PET-CT中诊断性CT的必要性与临床应用[J].国际放射医学核医学杂志,2005,29(5):197.
　JI Zhong-you.Necessity and clinical application of diagnostic CT in PET-CT scanner[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):197.
[5]陈香,赵军,管一晖.PET-CT常见伪影[J].国际放射医学核医学杂志,2005,29(5):201.
　CHEN Xiang,ZHAO Jun,GUAN Yi-hui.Common artifacts on PET-CT images[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):201.
[6]吴湖炳.18F-氟代脱氧葡萄糖PET-CT在头颈部肿瘤中的应用价值[J].国际放射医学核医学杂志,2005,29(5):205.
　WU Hu-bing.The clinical application value of 18F-FDG PET-CT on the head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):205.
[7]刘建军,黄钢.18F-氟代脱氧葡萄糖PET和PET-CT在转移性骨肿瘤中的应用研究[J].国际放射医学核医学杂志,2005,29(5):213.
　LIU Jian-jun,HUANG Gang.Application study of 18F-FDG PET and PET-CT on malignant bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):213.
[8]华逢春,管一晖,赵军.18F-氟代脱氧葡萄糖PET及PET-CT在淋巴瘤中的临床应用[J].国际放射医学核医学杂志,2005,29(5):216.
　HUA Feng-chun,GUAN Yi-hui,ZHAO Jun.18F-FDG PET and PET-CT imaging in lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):216.
[9]黎海涛.PET-CT在乳腺癌诊断中的应用价值[J].国际放射医学核医学杂志,2005,29(5):220.
　LI Hai-tao.The application value of PET-CT in the diagnosis of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):220.
[10]司宏伟,耿建华,陈盛祖.PET-CT在调强适形放疗中的临床应用[J].国际放射医学核医学杂志,2005,29(5):223.
　SI Hong-wei,GENG Jian-hua,CHEN Sheng-zu.Clinical application of PET-CT in intensive modulated radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(5):223.

备注/Memo

备注/Memo:
收稿日期:2005-07-08。
更新日期/Last Update: 1900-01-01